Core Viewpoint - Aohua Endoscopy's stock price has experienced fluctuations, with a year-to-date increase of 20.27% but a recent decline of 7.52% over the past five trading days, indicating potential volatility in the market [2]. Company Overview - Aohua Endoscopy, established on October 27, 1994, and listed on November 15, 2021, is located in Shanghai and specializes in the research, production, and sales of electronic endoscopy equipment and related surgical consumables [2]. - The company's main revenue sources are: endoscopy equipment (92.35%), endoscopy diagnostic consumables (3.71%), endoscopy maintenance services (3.58%), and leasing income (0.35%) [2]. Financial Performance - For the first half of 2025, Aohua Endoscopy reported a revenue of 260 million yuan, a year-on-year decrease of 26.36%, and a net profit attributable to shareholders of -40.76 million yuan, a significant decline of 820.03% [2]. - Cumulatively, the company has distributed 76.28 million yuan in dividends since its A-share listing, with 50.95 million yuan distributed over the past three years [3]. Shareholder Structure - As of June 30, 2025, the number of shareholders decreased by 2.51% to 3,921, while the average circulating shares per person increased by 2.58% to 34,344 shares [2]. - Notable institutional shareholders include: - Fortune Precision Medical Flexible Allocation Mixed A (third largest, holding 4.8351 million shares, increased by 2.07 million shares) - Huatai-PineBridge Innovation Medical Mixed A (fifth largest, new shareholder with 3.8984 million shares) - ICBC Frontier Medical Stock A (sixth largest, holding 3.0942 million shares, decreased by 0.8058 million shares) [3].
澳华内镜跌2.01%，成交额1919.84万元，主力资金净流入42.41万元